Orthofix International N.V. (OFIX) Downgraded by BidaskClub to “Hold”

Orthofix International N.V. (NASDAQ:OFIX) was downgraded by equities research analysts at BidaskClub from a “buy” rating to a “hold” rating in a research report issued on Tuesday, August 1st.

Other equities analysts also recently issued reports about the stock. SunTrust Banks, Inc. assumed coverage on shares of Orthofix International N.V. in a research note on Tuesday, May 23rd. They set a “buy” rating and a $49.00 price objective for the company. Zacks Investment Research downgraded shares of Orthofix International N.V. from a “hold” rating to a “sell” rating in a research note on Tuesday, May 9th. BTIG Research assumed coverage on shares of Orthofix International N.V. in a research note on Wednesday, June 21st. They issued a “buy” rating and a $52.00 price target for the company. Ladenburg Thalmann Financial Services assumed coverage on shares of Orthofix International N.V. in a research note on Wednesday, June 14th. They issued a “buy” rating and a $53.25 price target for the company. Finally, Langenberg & Company reissued a “buy” rating and issued a $53.25 price target on shares of Orthofix International N.V. in a research note on Wednesday, June 14th. Seven investment analysts have rated the stock with a buy rating, The company has an average rating of “Buy” and an average price target of $52.75.

Orthofix International N.V. (NASDAQ OFIX) opened at 48.00 on Tuesday. The company has a market capitalization of $872.16 million, a price-to-earnings ratio of 112.41 and a beta of 0.25. Orthofix International N.V. has a 12 month low of $32.51 and a 12 month high of $49.60. The company’s 50-day moving average price is $45.91 and its 200 day moving average price is $41.33.

Orthofix International N.V. (NASDAQ:OFIX) last issued its quarterly earnings data on Monday, August 7th. The medical device company reported $0.42 EPS for the quarter, beating the consensus estimate of $0.41 by $0.01. The firm had revenue of $108.90 million during the quarter, compared to the consensus estimate of $102.94 million. Orthofix International N.V. had a net margin of 1.88% and a return on equity of 9.96%. The company’s quarterly revenue was up 4.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.41 earnings per share. Analysts forecast that Orthofix International N.V. will post $1.57 EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: This article was first published by BNB Daily and is the sole property of of BNB Daily. If you are viewing this article on another domain, it was stolen and reposted in violation of United States & international copyright and trademark law. The original version of this article can be read at https://www.baseball-news-blog.com/2017/08/19/orthofix-international-n-v-ofix-cut-to-hold-at-bidaskclub-updated-updated.html.

In other news, insider Raymond Fujikawa sold 6,364 shares of the stock in a transaction that occurred on Thursday, August 10th. The shares were sold at an average price of $47.06, for a total transaction of $299,489.84. Following the sale, the insider now owns 31,084 shares in the company, valued at $1,462,813.04. The transaction was disclosed in a filing with the SEC, which is available at this link. Corporate insiders own 5.60% of the company’s stock.

Several large investors have recently bought and sold shares of OFIX. Comerica Bank purchased a new stake in Orthofix International N.V. during the first quarter worth approximately $783,000. BNP Paribas Arbitrage SA boosted its stake in Orthofix International N.V. by 68.9% in the first quarter. BNP Paribas Arbitrage SA now owns 4,656 shares of the medical device company’s stock worth $178,000 after buying an additional 1,900 shares during the last quarter. Bank of New York Mellon Corp boosted its stake in shares of Orthofix International N.V. by 122.5% in the first quarter. Bank of New York Mellon Corp now owns 242,068 shares of the medical device company’s stock valued at $9,236,000 after buying an additional 133,281 shares in the last quarter. American Century Companies Inc. boosted its stake in shares of Orthofix International N.V. by 68.9% in the first quarter. American Century Companies Inc. now owns 175,522 shares of the medical device company’s stock valued at $6,696,000 after buying an additional 71,599 shares in the last quarter. Finally, Old Mutual Global Investors UK Ltd. boosted its stake in shares of Orthofix International N.V. by 210.8% in the first quarter. Old Mutual Global Investors UK Ltd. now owns 8,059 shares of the medical device company’s stock valued at $307,000 after buying an additional 5,466 shares in the last quarter. Hedge funds and other institutional investors own 97.31% of the company’s stock.

About Orthofix International N.V.

Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim.

Analyst Recommendations for Orthofix International N.V. (NASDAQ:OFIX)

Receive News & Ratings for Orthofix International N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International N.V. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply